Prelude Therapeutics Announces $25 Million Private Placement
WILMINGTON, Del., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology...
Read moreWILMINGTON, Del., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology...
Read moreNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- IndexBox, a leading global research firm, has released an insightful report on...
Read moreNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- IndexBox, a prominent research firm, has just released an in-depth report on...
Read moreNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- IndexBox, a preeminent market research firm, has just released a new report...
Read moreNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- IndexBox, a leading provider of market research, has published a new report...
Read moreNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- IndexBox, a prominent market research firm, has recently published a new report...
Read moreNEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) -- IndexBox, a renowned market research firm, has recently published a comprehensive report...
Read moreWyoming, USA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals (OTC: RAFA) - We are pleased to announce that Rapharma...
Read moreUser-friendly interfaces and software upgrades in hematology analyzers enhance efficiency and accessibility for professionals.Wilmington, Delaware, United States, Dec. 11, 2023...
Read moreThe global online grocery market is anticipated to witness significant growth, with an estimated increase at a CAGR of 13.14%...
Read more